Assessment of toxicity in patients with ultra-central thoracic tumours treated with stereotactic body radiotherapy with a dose of 50 Gy in 5 fractions
In this cohort of patients with ultra-central thoracic lesions treated with 50 Gy in 5 fraction SBRT, no grade 3-5 acute or late toxicity was observed.
Authors
- Marie Duclos (ORCID: https://orcid.org/0000-0003-3324-2375)
- Neil Kopek
- Rie Nadia Asso (ORCID: https://orcid.org/0000-0003-2361-8439)
- Tanner Connell (ORCID: https://orcid.org/0000-0002-0146-0741)
- Sergio Faria (ORCID: https://orcid.org/0000-0003-0931-6514)
- M. Perna
- Bassam Abdulkarim (ORCID: https://orcid.org/0000-0002-0372-0412)
Institutions
- McGill University Health Centre (CA)
- Instituto do Câncer do Estado de São Paulo (BR)
Publication Details
- Journal
- Reports of Practical Oncology & Radiotherapy
- Published
- 2025-10-03
- DOI
- https://doi.org/10.5603/rpor.107741
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00